VIM and lung adenocarcinoma: To further address the clinical relevance of this hypothesis, we first utilized our proteomic and transcriptomic data from a prospectively collected lung adenocarcinoma cohort (Appendix Table S6) of Taiwan Cancer Moonshot (Chen et al, 2020) to examine the correlation between MTAP/vimentin and PRMT5/vimentin.